roypounder.apt

@APandT new papers in AP&T, summaries free-to-view. 2023 Impact Factor is 6.6, ranking AP&T 18/97 for journals in Gastroenterology & Hepatology.

[roypounder.apt @APandT]

Read open access via https://t.co/bXd9UABYRM "Development of a Clinical and Biomarker-Based Score to Predict Microscopic Colitis in Patients With Chronic Watery Diarrhoea"
#GItwitter #colitis #diarrhoea

[roypounder.apt @APandT]

Available to read 'open access' via https://t.co/ciNm3KvHde "Clinical Trial: Capsule Sponge as a Non-Endoscopic Monitoring Tool in Eosinophilic Oesophagitis—A Prospective Real–World Multicentre Study"
#GItwitter #EoE

[roypounder.apt @APandT]

"Management and Outcomes of Bleeding Ectopic Varices in Patients With Liver Cirrhosis: A Systematic Review and Pooled Analysis" published at https://t.co/6W4zUikIOf
#livertwitter #varices #cirrhosis

[roypounder.apt @APandT]

Read open access via https://t.co/EMXQFA0jsA "Colonic Mast Cell Density and Diarrhoea: Evidence Against a Threshold Effect in Biopsies From 3508 Patients"
#GItwitter #diarrhoea #colon

[roypounder.apt @APandT]

"Baseline Clearance and Early Troughs Identify Candidates for Early Therapeutic Drug Monitoring During Infliximab Induction in Inflammatory Bowel Disease" avaible to read via https://t.co/gLiw0cN1Is
#GItwitter #IBD #infliximab

[roypounder.apt @APandT]

Read open access via https://t.co/6oisOvF1uU "Beyond Anticoagulant Exposure: Determinants of Mortality After Gastrointestinal Bleeding Across DOAC, Warfarin and Non-Anticoagulated Patients".
#GItwitter #GIbleeding

[roypounder.apt @APandT]

"Incidence and Risk Factors for C. difficile Reinfection After Faecal Microbiota Transplantation or Antibiotic Therapy" by Kelly CR et al is available to read at https://t.co/fXSMokVL96
#GItwitter #microbiota #CDI #FMT

[roypounder.apt @APandT]

Read open access via https://t.co/VSjjmnlPt1 "Eosinophilic Oesophagitis and Incidence of Gastrointestinal Cancer: A Population-Based Cohort Study"
#GItwitter #oesophagus #GIcancer

[roypounder.apt @APandT]

Read open access via https://t.co/fu7UEmcp6Y "Clinical Course and Predictors of Biologic Therapy, Hospitalisation and Surgery: A Five-Year Prospective Study in Newly Diagnosed Inflammatory Bowel Disease"
#GItwitter #IBD #surgery

[roypounder.apt @APandT]

"Clinical Trial: Dupilumab Improves Eosinophilic Oesophagitis Outcomes Versus Placebo Regardless of Comorbidities or Treatment History in a Randomised Clinical Trial" is available to read open access via https://t.co/PIipNEHZEf
#EoE #GItwitter

[roypounder.apt @APandT]

Read via https://t.co/CDkoEl5Xb9 "Systematic Review: Inclusion of Patients With Difficult-to-Treat Inflammatory Bowel Disease in Randomized Controlled Trials of Advanced Therapies"
#GItwitter #IBD

[roypounder.apt @APandT]

Read via https://t.co/dJC6SONml4 "Accelerated Biological Aging in Cholestatic Liver Disease: Telomere Attrition and Association With Disease Severity"
#livertwitter #PSC #PBC

[roypounder.apt @APandT]

"Review Article: Cancer Surveillance for Early Detection of Liver Cancer in Patients with HBV Infection" - read via https://t.co/k0JGdoEmtg
#HBV #livertwitter #HCC

[roypounder.apt @APandT]

"Revisiting Ferritin-IgG Score to Predict Complete Biochemical Response in Autoimmune Hepatitis" is available to read open access via https://t.co/S9WLgAYJiJ
#livertwitter #AIH

[roypounder.apt @APandT]

Read via https://t.co/Yi2lAxCOac "Persistence, Safety and Pharmacokinetics of Vedolizumab After Switching to the Subcutaneous Route in a Prospective French National Cohort Study"
#GItwitter #IBD #vedolizumab

[roypounder.apt @APandT]

"Meta-Analysis: The Placebo Response in Modern Treatments for Cholestatic Pruritus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials" - read via https://t.co/Nw3VsVbJ3I
#livertwitter #metanalysis #pruritus

[roypounder.apt @APandT]

Read open access via https://t.co/1aEWoeqP6i "Pathogen-Specific Bloodstream Infections Associated With Tumour Necrosis Factor-α Inhibitors, Vedolizumab and Ustekinumab in Inflammatory Bowel Disease: A Danish Nationwide Case-Control Study 2010–2024"
#IBD #GItwitter #TNF

[roypounder.apt @APandT]

"Development and Prospective Validation of a Machine Learning-Based Mobile Application (CROHN'S AID) for Differentiating Crohn's Disease From Intestinal Tuberculosis in Tuberculosis-Endemic Regions" is now published at https://t.co/5Bddznmaqk
#GItwitter #Crohns #IBD

[roypounder.apt @APandT]

Available to read 'open access' via https://t.co/ul0nqvEzKo "Medication Use and Risk of Microscopic Colitis: A Propensity-Matched Analysis of US Adults ≥ 50 Years (2014–2024)"
#GItwitter #microscopiccolitis #NSAIDs #PPIs #SSRIs

[roypounder.apt @APandT]

Read open access via https://t.co/IymsLK2Yi0 "Carriage of the Laboratory of Genetics and Physiology Protein 2 Q425R Variant Reduces Liver Disease Severity in European Patients With Chronic Hepatitis Delta"
#livertwitter #HDV #HBV #HCC